Switch to:
More From Other Websites
5 Things Bristol-Myers Squibb's Management Wants You to Know Apr 29 2017
The High Hope of Exelixis’s Cabometyx Label Expansion Apr 28 2017
Exelixis, Inc. – Value Analysis (NASDAQ:EXEL) : April 27, 2017 Apr 27 2017
Inside Exelixis’s Robust Growth Strategy for Cabometyx Apr 27 2017
Exelixis’s Tough Competition in Renal Cell Carcinoma Apr 27 2017
Behind Exelixis’s Successful Commercial Launch of Cabometyx in 2016 Apr 27 2017
Understanding Exelixis’s Operating Expense Expectations for 1Q17 Apr 26 2017
Inside Exelixis’s Analyst Recommendations after 1Q17 Apr 26 2017
Can Exelixis Beat the Analyst Revenue Estimates in 1Q17? Apr 26 2017
Exelixis, Inc. breached its 50 day moving average in a Bullish Manner : EXEL-US : April 26, 2017 Apr 26 2017
Exelixis (EXEL) Q1 Earnings: Will the Stock Disappoint? Apr 25 2017
Exelixis to Present at the Deutsche Bank 42nd Annual Health Care Conference on May 3 Apr 24 2017
Read This Before You Buy Biotech Stocks Apr 23 2017
Here's Why the Best Is Yet to Come for Exelixis, Inc. Apr 20 2017
ETFs with exposure to Exelixis, Inc. : April 19, 2017 Apr 19 2017
Exelixis to Release First Quarter 2017 Financial Results on Monday, May 1, 2017 Apr 18 2017
Exelixis, Inc.: Time to Move On? Apr 18 2017
3 Stocks That Turned $5,000 Into More Than $18,000 in a Year or Less Apr 12 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK